Decision expected on new Alzheimer’s treatment - The drug is one of the new ‘disease modifying’ treatments for Alzheimer’s ...

The most effective drug for Alzheimer’s will be blocked for use on the NHS on Wednesday. Regulators are expected to declare ...

In late 2022, the results of a groundbreaking stage three trial for a ‘miracle’ new Alzheimer’s drug lecanemab were hailed as ...

Britain's National Health Service (NHS) will block Eli Lilly's Alzheimer's drug donanemab on Wednesday, deeming it too ...

Leqembi, first FDA-approved Alzheimer's drug, faces EMA rejection, but shares could potentially surge soon. See why I rate ...

An Alzheimer’s treatment from idea to market can take up to 20 years. After a long hiatus, the U.S. Food and Drug ...

Alzheimer's disease may damage the brain in two distinct phases, based on new research using sophisticated brain mapping ...

New details have emerged into how Alzheimer’s disease affects the brain. Researchers have identified cellular changes in the brains of people with the disease — and a timeline of when they occur.

Posterial Cortical Atrophy, sometimes called Benson’s disease, is a rare degenerative brain condition that affects the back ...

An analysis of the genetic activity of brain cells in individuals who have died with Alzheimer's disease has revealed the ...

Roche drops a third Alzheimer’s candidate this year, terminating a partnership with UCB just four years after agreeing to ...

Neurophet has specialized in developing solutions for diagnosis support, treatment guides, and treatment devices targeting ...